Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

US Patent 9045420 · Granted Jun 2, 2015

Estimated economic value: $71,334,000

Assignee

Inventors

View full patent text on Google Patents →